Erratum : Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913
© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V..
[This corrects the article DOI: 10.1016/j.apsb.2021.03.002.].
| Errataetall: |
ErratumFor: Acta Pharm Sin B. 2021 Jul;11(7):1903-1913. - PMID 34386327 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Acta pharmaceutica Sinica. B - 13(2023), 8 vom: 02. Aug., Seite 3579-3580 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yu, Ziru [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.09.2023 published: Print-Electronic ErratumFor: Acta Pharm Sin B. 2021 Jul;11(7):1903-1913. - PMID 34386327 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.apsb.2023.05.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361531168 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361531168 | ||
| 003 | DE-627 | ||
| 005 | 20231226085335.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.apsb.2023.05.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM361531168 | ||
| 035 | |a (NLM)37655326 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yu, Ziru |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Erratum |b Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Acta Pharm Sin B. 2021 Jul;11(7):1903-1913. - PMID 34386327 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. | ||
| 520 | |a [This corrects the article DOI: 10.1016/j.apsb.2021.03.002.] | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Kong, Dewen |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Xiaoyue |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Guanhua |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta pharmaceutica Sinica. B |d 2012 |g 13(2023), 8 vom: 02. Aug., Seite 3579-3580 |w (DE-627)NLM227628217 |x 2211-3835 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:8 |g day:02 |g month:08 |g pages:3579-3580 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.apsb.2023.05.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 8 |b 02 |c 08 |h 3579-3580 | ||